EX-99.1 2 d798300dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Joint Filing Agreement

Each of the undersigned hereby expresses its agreement that the attached Schedule 13D (and any amendments thereto) relating to the Common Stock of Tokai Pharmaceuticals, Inc. is filed on behalf of each of the undersigned.

 

Date: October 1, 2014     NOVARTIS BIOVENTURES LTD.
    By:  

/s/ Michael Jones

    Name:   Michael Jones
    Title:   Director
    By:  

/s/ Laurieann Chaikowsky

    Name:   Laurieann Chaikowsky
    Title:   Authorised Signatory
    NOVARTIS AG
    By:  

/s/ Michael Jones

    Name:   Michael Jones
    Title:   Authorised Signatory
    By:  

/s/ David Middleton

    Name:   David Middleton
    Title:   Authorised Signatory